Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from EMvision Medical Devices Ltd. ( (AU:EMV) ) is now available.
EMvision Medical Devices Ltd has announced the quotation of 205,574 fully paid ordinary securities on the ASX, effective September 24, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its growth initiatives, potentially impacting its market position and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:EMV) stock is a Buy with a A$2.95 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMvision Medical Devices Ltd operates in the medical technology industry, focusing on developing and commercializing innovative imaging solutions for healthcare. The company is known for its portable brain scanner technology, which aims to provide rapid diagnosis and monitoring of brain conditions, with a market focus on improving patient outcomes and reducing healthcare costs.
Average Trading Volume: 47,309
Technical Sentiment Signal: Buy
Current Market Cap: A$164.2M
For detailed information about EMV stock, go to TipRanks’ Stock Analysis page.